Skip to main content

Year: 2021

Teekay LNG Partners Reports Third Quarter 2021 Results

HighlightsGAAP net income attributable to the partners and preferred unitholders of $67.0 million and GAAP net income per common unit of $0.68 in the third quarter of 2021. Adjusted net income(1) attributable to the partners and preferred unitholders of $54.7 million and adjusted net income per common unit of $0.54 in the third quarter of 2021 (excluding other items listed in Appendix A to this release). Total adjusted EBITDA(1) of $178.0 million in the third quarter of 2021. On October 4, 2021, announced agreement for Stonepeak to acquire 100 percent of Teekay LNG’s outstanding common units and general partner units for $17.00 per unit. The Transaction (as defined below) is subject to certain closing conditions, including approval by the holders of a majority of Teekay LNG’s outstanding common units. A special meeting of...

Continue reading

Agora, Inc. to Report Third Quarter 2021 Financial Results on November 15, 2021

SANTA CLARA, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) — Agora, Inc. (NASDAQ: API) (“Agora”), a pioneer and leading platform for real-time engagement APIs, announced today that it will release financial results for the third quarter ended September 30, 2021 after the close of U.S. markets on November 15, 2021. Agora will host a conference call to discuss the financial results at 5:00 p.m. Pacific Time / 8:00 p.m. Eastern Time on the same day. Details for the conference call are as follows: Event title: Agora, Inc. 3Q 2021 Financial Results Conference ID: 5319139 Direct Event online registration: http://apac.directeventreg.com/registration/event/5319139 Please register in advance of the conference using the link provided above. Upon registering, you will be provided with participant dial-in numbers, Direct Event passcode and unique...

Continue reading

ISC Reports 2021 Third Quarter Financial Results

REGINA, Saskatchewan, Nov. 03, 2021 (GLOBE NEWSWIRE) — Information Services Corporation (TSX:ISV) (“ISC” or the “Company”) today reported on the Company’s financial results for the third quarter ended September 30, 2021. 2021 Third Quarter HighlightsRevenue was $41.4 million for the quarter, an increase of 11 per cent compared to the third quarter of 2020. Net income was $9.7 million or $0.55 per basic share and $0.53 per diluted share compared to $5.0 million or $0.29 per basic and diluted share in the third quarter of 2020. EBITDA was $17.5 million compared to $10.9 million for the same quarter last year. EBITDA margin was 42.3 per cent for the quarter compared to 29.4 per cent last year. Adjusted EBITDA was $17.3 million for the quarter compared to $13.2 million in the same quarter last year. Adjusted EBITDA margin was 41.8...

Continue reading

Workplace Technology Dividend Fund Announces Exchange Ratios

TORONTO, Nov. 03, 2021 (GLOBE NEWSWIRE) — Middlefield Group, on behalf of Workplace Technology Dividend Fund (the “Fund”), is pleased to announce the exchange ratios for the exchange offer by the Fund (the “Exchange Option”) being made under the final prospectus of the Fund dated October 13, 2021. The Fund’s investment objectives are to provide holders of units of the Fund (“Units”) with:  (i)   stable monthly cash distributions, and  (ii)   enhanced long-term total return through capital appreciation of the Fund’s investment portfolio;       through a diversified, actively managed portfolio comprised primarily of dividend paying securities of international issuers focused on, involved in, or that derive a significant portion of their revenue from business models that provide technology-based solutions to...

Continue reading

PacBio’s Sequel IIe Selected by Prenetics to Build Personalized Genomics for Healthcare

Leading global genomics and diagnostic testing firm adds more comprehensive genetic information to its services. MENLO PARK, Calif. and HONG KONG, Nov. 03, 2021 (GLOBE NEWSWIRE) — PacBio will be providing its high-quality, highly accurate sequencing platforms to Prenetics Group Limited, a leading global genomics and diagnostic testing company, as the firm adds more comprehensive genetic screening services including carrier screening and cancer-risk screening in Hong Kong, Southeast Asia and in the United Kingdom. “With the global success of CircleDNA for consumers, Circle Medical will be a physician-only product to specifically cater to a physician’s specialty. The partnership with PacBio enables us to expand the utility and opportunity of next generation sequencing technologies in both consumer and clinical settings.” said Danny...

Continue reading

Tenaris Announces 2021 Third Quarter Results

The financial and operational information contained in this press release is based on unaudited consolidated condensed interim financial statements presented in U.S. dollars and prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standard Board and adopted by the European Union, or IFRS. Additionally, this press release includes non-IFRS alternative performance measures i.e., EBITDA, Free cash flow and Net cash / debt. See exhibit I for more details on these alternative performance measures. LUXEMBOURG, Nov. 03, 2021 (GLOBE NEWSWIRE) — Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) (“Tenaris”) today announced its results for the quarter and nine months ended September 30, 2021 with comparison to its results for the quarter and nine months ended September 30, 2020. Summary...

Continue reading

XP Inc. Reports 3Q21 Financial Results

SÃO PAULO, Brazil, Nov. 03, 2021 (GLOBE NEWSWIRE) — XP Inc. (NASDAQ: XP) (“XP” or the “Company”), a leading tech-enabled platform and a trusted pioneer in providing low-fee financial products and services in Brazil, reported today its financial results for the third quarter of 2021. To our shareholders “In adversity, some give up, while others exceed records.” Ayrton Senna. This phrase has been inspiring us throughout our history. The ownership culture and our partnership, currently with more than 800 partners and 6,000 empowered executives acting as CEOs, coupled with our resilience and tenacity, were the factors that made us overcome various moments of uncertainty we have been through. It was like that in 2001, 2005, 2007, 2014 and 2019, and it will be no different today. Whether or not we are in a crisis we cannot...

Continue reading

STEP Energy Services Ltd. Reports Third Quarter 2021 Results and Announces Executive Leadership Changes

CALGARY, Alberta, Nov. 03, 2021 (GLOBE NEWSWIRE) — STEP Energy Services Ltd. (the “Company” or “STEP”) is pleased to announce its financial and operating results for the three and nine months ended September 30, 2021. The following press release should be read in conjunction with the management’s discussion and analysis (“MD&A”) and unaudited condensed consolidated interim financial statements and notes thereto as at and for the three and nine months ended September 30, 2021 (the “Quarterly Financial Statements”). Readers should also refer to the “Forward-looking information & statements” legal advisory and the section regarding “Non-IFRS Measures” at the end of this press release. All financial amounts and measures are expressed in Canadian dollars unless otherwise indicated. Additional information about STEP is available...

Continue reading

MediciNova Announces New Data regarding MN-166 (ibudilast) in Glioblastoma to be Presented at the Annual Meeting of the Society for Neuro-Oncology

LA JOLLA, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that MediciNova’s collaborator, Dr. Justin Lathia, Co-Director of the Brain Tumor Research and Therapeutic Development Center of Excellence at Cleveland Clinic Lerner Research Institute, and Professor, Department of Molecular Medicine at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, will present new data regarding MN-166 (ibudilast) from a glioblastoma animal model study at the 26th Annual Meeting of the Society for Neuro-Oncology (SNO) to be held November 18 – 21, 2021 in Boston. The presentation details are as follows: Date: Saturday November 20, 2021Session...

Continue reading

Bunker Hill Files Updated PEA Technical Report and Provides Mine Restart Project Update

TORONTO, Nov. 03, 2021 (GLOBE NEWSWIRE) — Bunker Hill Mining Corp. (the “Company”) (CSE: BNKR, OTCQB: BHLL) is pleased to announce the filing of an updated independent Preliminary Economic Assessment (“PEA”) for the restart of the Bunker Hill Mine in the world-class Silver Valley region of Idaho, USA, and to provide a mine restart project update. HIGHLIGHTS:  NI 43-101 compliant technical report filed for updated PEA announced on September 20, 2021 Updated PEA contemplates materially improved financial returns from prior PEA: $143M NPV (+42% increase), 35% IRR, 2.6-year payback, $25M annual average FCF (+28% increase) at $1.15/lb Zn, $0.90/lb Pb, $20/oz Ag Restart plan continues to be refined through progression of engineering, design, test-work and trade-off studies in support of the on-going project financing process, to support...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.